Introduction

Lipeng Qiu received Ph.D. degree in Pharmaceutics from Shenyang Pharmaceutical University in 2014, and he is working in Jiangnan University an associate professor. He carried out studies in the University of Oxford as a visiting scholar for one year. His research interests focus on Pharmaceutical Nanotechnology, Novel Drug Delivery Systems, and Multifunctional Nanomaterials for Controlled Drug Delivery. He has published more than 50 peer-reviewed research papers with over 1300 citations, and received several new drug patents.

Key Publications of First/Corresponding author

[1] Enhanced Effect of pH-Sensitive Mixed Copolymer Micelles for Overcoming Multidrug Resistance of Doxorubicin. Biomaterials. 2014, 35(37): 9877-9887.

[2] Self-assembled pH-responsive Hyaluronic Acid-g-poly (L-histidine) Copolymer Micelles for Targeted Intracellular Delivery of Doxorubicin. Acta Biomaterialia. 2014, 10 (5): 2024-2035.

[3] cRGDyK modified pH responsive nanoparticles for specific intracellular delivery of doxorubicin. Acta Biomaterialia. 2016, 30: 285-298.

[4] pH-Sensitive degradable polymeric micelles for bio-triggered targeted anti-tumor drug delivery, J Control Release. 2017, 259: e86-e87.

[5] pH-triggered degradable polymeric micelles for targeted anti-tumor drug delivery. Mater Sci Eng C Mater Biol Appl. 2017, 78: 912-922.

[6] Designing heparan sulfate-based biocompatible polymers and their application for intracellular stimuli-sensitive drug delivery. Mater Sci Eng C Mater Biol Appl. 2019, 94: 465-476.

[7] Derma roller® microneedles-mediated transdermal delivery of doxorubicin and celecoxib co-loaded liposomes for enhancing the anticancer effect. Mater Sci Eng C Mater Biol Appl. 2019, 99:1448-1458.

[8] Elucidation of cellular uptake and intracellular trafficking of heparosan polysaccharide-based micelles in various cancer cells. Int J Biol Macromol. 2019, 130:755-764.

[9] Redox-responsive biocompatible nanocarriers based on novel heparosan polysaccharides for intracellular anticancer drug delivery. Asian J Pharm Sci. 2020, 15(1): 83-94.

[10] A facile synthesis of uniform hollow MIL-125 titanium-based nanoplatform for endosomal esacpe and intracellular drug delivery. Chem Eng J, 2020, 396: 125246.

[11] Overcoming multidrug resistance by intracellular drug release and inhibiting p-glycoprotein efflux in breast cancer. Biomed Pharmacother, 2021, 134: 111108.

[12] Bacteria-mediated cancer therapies: opportunities and challenges. Biomater Sci. 2021, 9(17): 5732-5744.

[13] Biological role of heparan sulfate in osteogenesis: A review. Carbohydr Polym. 2021, 272: 118490.

[14] Carbon Nitride Nanosheets for Imaging Traceable CpG Oligodeoxynucleotide Delivery. ACS Appl Nano Mater, 2021, 4(8): 8546-8555.

[15] Fabrication of pH/Reduction Sensitive Polyethylene Glycol-Based Micelles for Enhanced Intracellular Drug Release. Pharmaceutics. 2021, 13(9): 1464.

[16] Stimuli-responsive, dual-function prodrug encapsulated in hyaluronic acid micelles to overcome doxorubicin resistance. Acta Biomater. 2021, 140:686-699.

[17] Dexamethasone microspheres and celecoxib microcrystals loaded into injectable gels for enhanced knee osteoarthritis therapy. Int J Pharm, 2022, 622, 121802.

[18] Enzyme-loaded glycogen nanoparticles with tumor-targeting Activatable host-guest supramolecule for augmented chemodynamic therapy. Int J Biol Macromol, 2022, 217: 878-889.

[19] Engineered bacteria combined with doxorubicin nanoparticles suppress angiogenesis and metastasis in murine melanoma models. Acta Biomater, 2023, 158:734-746.

[20] Oral delivery of layer-by-layer coated exosomes for colitis therapy. J Control Release, 2023, 354:635-650.

Funds

1.National Key Research and Development Program of China (2021YFC2103100).

2.National Natural Science Foundation of China (81503007).

3.China Postdoctoral Science Foundation (2019M660166).

4.Natural Science Foundation of Jiangsu Province (BK20201344).

5.Ministry of Education of China (JUSRP51516)

Honors

1.Excellent Advisor for the 14th Challenge Cupnational Undergraduate Curricular Academic Science and Technology Contest.

2.The Advisor for Merit Graduate of 18新利体育备用网址

3.First Prize of Teaching Competition for Young Teachers in 18新利体育备用网址

4.The Title of “Good Young Scholar” in 18新利体育备用网址

5.Second Prize for Science & technology Development/Achievement of the Ministry of Education.

6.First prize for Science and Technology Progress of China General Chamber of Commerce.

Address:School of Life Science and Health Engineering,1800 Lihu Road, Wuxi, Jiangsu, China

Zip code:214122

Phone0086-51085911900

E-mail:qiulp@jiangnan.edu.cn